The Latest on New LDL-cholesterol Lowering Drugs and Clinical Trials and Johns Hopkins

Cardiologist Thorsten Leucker discusses the latest on new LDL-cholesterol lowering drugs, inflammation and clinical trials being conducted at Johns Hopkins.

Created by

Johns Hopkins Medicine

Related Presenters

Thorsten Martin Leucker, MD, PhD

Thorsten Martin Leucker, MD, PhD

Associate Director, Cardiology Fellowship Program

View full profile